Published in Hypertension on February 01, 1995
Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc Natl Acad Sci U S A (1997) 1.78
Heart failure development in rats with ascending aortic constriction and angiotensin-converting enzyme inhibition. Br J Pharmacol (2000) 0.87
Role of the renin-angiotensin system in cardiac hypertrophy induced in rats by hyperthyroidism. Am J Physiol (1997) 0.86
Anti-remodeling effects of rapamycin in experimental heart failure: dose response and interaction with angiotensin receptor blockade. PLoS One (2013) 0.86
The left ventricle in aortic stenosis: evidence for the use of ACE inhibitors. Heart (2006) 0.84
Local renin-angiotensin system contributes to hyperthyroidism-induced cardiac hypertrophy. J Endocrinol (1999) 0.82
Sarcoplasmic reticulum function and carnitine palmitoyltransferase-1 inhibition during progression of heart failure. Br J Pharmacol (2000) 0.81
Adaptive and genetic alterations of the renin angiotensin system in cardiac hypertrophy and failure. Basic Res Cardiol (1996) 0.79
Alteration of growth responses in established cardiac pressure overload hypertrophy in rats with aortic banding. J Clin Invest (1995) 0.79
Keeping the heart empty and beating: an alternative technique to preserve hypertrophied hearts during valvular surgery. J Cardiothorac Surg (2015) 0.75
Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med (1994) 3.11
Large scale association analysis of novel genetic loci for coronary artery disease. Arterioscler Thromb Vasc Biol (2009) 2.71
DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids. EMBO J (2001) 2.43
Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J (2003) 2.40
Subcellular compartmentalization of adeno-associated virus type 2 assembly. J Virol (1997) 2.31
Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation (1995) 2.25
Localization of a small genomic region associated with elevated ACE. Am J Hum Genet (2000) 2.13
31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation (1992) 1.71
Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in the nervous system. Hum Gene Ther (1999) 1.64
Acute hemodynamic interaction of aspirin and ticlopidine with enalapril: results of a double-blind, randomized comparative trial. Circulation (1998) 1.58
Siblings of myocardial infarction patients are overlooked in primary prevention of cardiovascular disease. Eur Heart J (2001) 1.53
The D-allele of the ACE polymorphism is related to increased QT dispersion in 609 patients after myocardial infarction. Eur Heart J (2001) 1.52
Risk predictors in patients scheduled for percutaneous coronary revascularization. Catheter Cardiovasc Interv (1999) 1.43
Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res (1991) 1.43
Differential effects of growth hormone on cardiomyocyte and extracellular matrix protein remodeling following experimental myocardial infarction. Cardiovasc Res (1998) 1.41
Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation (1997) 1.40
Long-term effects of in-hospital cardiac rehabilitation on the cardiac risk profile. A case-control study in pairs of siblings with myocardial infarction. Eur Heart J (2001) 1.40
Cardiac risk factor management. Experience of an outpatient hypertension clinic. Med J Aust (1991) 1.40
Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. Cardiovasc Res (1998) 1.29
Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J Hypertens (1998) 1.28
Control of adeno-associated virus type 2 cap gene expression: relative influence of helper virus, terminal repeats, and Rep proteins. J Virol (1997) 1.28
Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: a population-based study. J Clin Endocrinol Metab (2000) 1.25
Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation (1994) 1.22
Deletion-type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilation after anterior myocardial infarction. Captopril and Thrombolysis Study Investigators. J Am Coll Cardiol (1995) 1.20
Body composition and prevalence of left ventricular hypertrophy. Circulation (2000) 1.20
Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey. BMJ (1998) 1.19
Establishment and characterization of the follicular thyroid carcinoma cell line ML-1. J Mol Med (Berl) (2000) 1.15
Evidence for a vasopressin system in the rat heart. Circ Res (1999) 1.15
Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts. Am J Physiol (1994) 1.13
Association between a polymorphism in the G protein beta3 subunit gene and lower renin and elevated diastolic blood pressure levels. Hypertension (1998) 1.12
The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. Am J Cardiol (2001) 1.12
Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J Hypertens (2000) 1.12
Comparative coronary anatomy in six twin pairs with coronary artery disease. Heart (2000) 1.11
Diuretic treatment and diuretic resistance in heart failure. Am J Med (1999) 1.10
The associations of body size and body composition with left ventricular mass: impacts for indexation in adults. J Am Coll Cardiol (1998) 1.09
The effects of weightlessness on the human organism and mammalian cells. Curr Mol Med (2011) 1.08
Age-related differences in the expression of proto-oncogene and contractile protein genes in response to pressure overload in the rat myocardium. J Clin Invest (1992) 1.06
Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition. Diabetes (1994) 1.02
Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation (2000) 1.02
Prevalence of undiagnosed Type-2-diabetes mellitus and impaired fasting glucose in German primary care: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS). Exp Clin Endocrinol Diabetes (2007) 1.02
BNP as a marker of diastolic dysfunction in the general population: Importance of left ventricular hypertrophy. Eur J Heart Fail (2005) 0.98
Renal arterial stenoses: spiral CT angiography. Radiology (1993) 0.98
Indexation of left ventricular mass in adults with a novel approximation for fat-free mass. J Hypertens (2001) 0.97
Induction of three-dimensional assembly and increase in apoptosis of human endothelial cells by simulated microgravity: impact of vascular endothelial growth factor. Apoptosis (2006) 0.97
Wells' syndrome associated with idiopathic hypereosinophilic syndrome. Br J Dermatol (1997) 0.97
Differential expression of cardiac ANP and BNP in a rabbit model of progressive left ventricular dysfunction. Cardiovasc Res (2001) 0.96
Inhibition of synthesis of endothelium-derived nitric oxide in conscious dogs. Hemodynamic, renal, and hormonal effects. Am J Hypertens (1992) 0.96
Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based study. J Am Coll Cardiol (1998) 0.95
Expression of immediate early genes after cardioplegic arrest and reperfusion. Ann Thorac Surg (1997) 0.95
Marked suppression of renin levels by beta-receptor blocker in patients treated with standard heart failure therapy: a potential mechanism of benefit from beta-blockade. J Intern Med (2001) 0.94
Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension. Am Heart J (1998) 0.94
[Distribution, determinants and reference values of left ventricular parameters in the general population--results of the MONICA/KORA echocardiography studies]. Gesundheitswesen (2005) 0.93
Changes in type VI adenylyl cyclase isoform expression correlate with a decreased capacity for cAMP generation in the aging ventricle. Circ Res (1994) 0.93
Evaluation of the angiotensinogen locus in human essential hypertension: a European study. Hypertension (1998) 0.92
Effectiveness of and adverse events after percutaneous coronary intervention in patients with mild versus severe renal failure. Am J Cardiol (2001) 0.92
Gender specific differences in left ventricular adaptation to obesity and hypertension. J Hum Hypertens (1998) 0.91
Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade. Am J Cardiol (1984) 0.91
Frequency of calpain-3 c.550delA mutation in limb girdle muscular dystrophy type 2 and isolated hyperCKemia in German patients. Clin Neuropathol (2007) 0.91
Vasopressin and renin in high output heart failure of rats: hemodynamic effects of elevated plasma hormone levels. J Cardiovasc Pharmacol (1985) 0.91
Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass. Heart (1997) 0.90
Effects of long-term angiotensin converting enzyme inhibition on myocardial hypertrophy in experimental aortic stenosis in the rat. Am J Cardiol (1988) 0.90
Familial predisposition of left ventricular hypertrophy. J Am Coll Cardiol (1999) 0.90
Effectiveness of converting enzyme inhibition (enalapril) for mild congestive heart failure. Am J Cardiol (1986) 0.87
Renin-angiotensin system gene polymorphisms: potential mechanisms for their association with cardiovascular diseases. Eur J Pharmacol (2000) 0.87
Changes in CD44 and ApoE immunoreactivities due to retinal pathology of man and rat. J Hirnforsch (1997) 0.87
Inhibition of cyclooxygenase-2 attenuates urinary prostanoid excretion without affecting renal renin expression. Pflugers Arch (2001) 0.86
Intrarenal renin-angiotensin system in renal physiology and pathophysiology. Kidney Int Suppl (1993) 0.86
Fates of genetically engineered haematopoietic and mesenchymal stem cell grafts in normal and injured rat hearts. J Tissue Eng Regen Med (2008) 0.86
Failure to achieve recommended LDL cholesterol levels by suboptimal statin therapy relates to elevated cardiac event rates. Int J Cardiol (2005) 0.86
Vasopressin, renin and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to idiopathic dilated cardiomyopathy. Am J Cardiol (1986) 0.86
The deletion polymorphism of the angiotensin-converting enzyme gene is related to phenotypic differences in human arteries. Eur Heart J (1996) 0.86